非小细胞肺癌临床实践指南（2017 年第 5 版），NCCN 肿瘤学临床实践指南
Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.
出版信息
J Natl Compr Canc Netw. 2017 Apr;15(4):504-535. doi: 10.6004/jnccn.2017.0050.
PMID:28404761
Abstract
This selection from the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) focuses on targeted therapies and immunotherapies for metastatic NSCLC, because therapeutic recommendations are rapidly changing for metastatic disease. For example, new recommendations were added for atezolizumab, ceritinib, osimertinib, and pembrolizumab for the 2017 updates.
摘要
本指南节选自 NCCN 非小细胞肺癌（NSCLC）指南，重点介绍转移性 NSCLC 的靶向治疗和免疫治疗，因为转移性疾病的治疗建议正在迅速变化。例如，在 2017 年更新中新增了阿特珠单抗、塞瑞替尼、奥希替尼和帕博利珠单抗的新建议。
Zotero 插件